Cipla jumps 8% despite 55% profit drop: Why are brokerages positive on the drugmaker
Cipla's share price rose 7.9% despite a weak quarterly performance, with most brokerage houses giving a positive recommendation. JM Financial upgraded the stock to 'Buy' with a target price of Rs 1,546, while Nomura maintained its 'Buy' rating with a target price of Rs 1,510. Motilal Oswal retained its 'Neutral' call with a target price of Rs 1,380.